iShares US Pharmaceuticals ETF
IHE
IHE
101 hedge funds and large institutions have $317M invested in iShares US Pharmaceuticals ETF in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 47 reducing their positions, and 6 closing their positions.
Holders
101
Holders Change
+6
Holders Change %
+6.32%
% of All Funds
2.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
16
Reduced
47
Closed
6
Calls
$860K
Puts
$391K
Net Calls
+$469K
Net Calls Change
+$469K
Top Buyers
1 |
TSS
1
Two Sigma Securities
New York
|
$10.4M |
2 |
2
Morgan Stanley
New York
|
$44.3M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$6.79M |
4 |
4
Jane Street
New York
|
$6.62M |
5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$5.59M |